Windsor James Brian
- SEC CIK
- 0001790933
In the past year, 1 open-market purchase filing worth $25.0K and no sales.
Current role at each company
- RNTX Rein Therapeutics, Inc.See Remarksas of May 13, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $25.0K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$25.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Windsor James Brian as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 13, 2026 (view filing) | Apr 30 | 13 daysLate | Windsor James BrianSee Remarks | PPurchaseCommon stock , $0.001 par value | +25.0K | $1.00 | +$25.0K | +1,221.9%27.0K after | |
| Dec 9, 2024 (view filing) | Dec 5 | 4 days | Windsor James BrianPresident and CEO | PPurchase | +400 | $2.24 | +$897.61 | New position161 after | 2 lots |
| Dec 18, 2023 (view filing) | Dec 15 | 3 days | Windsor James BrianPresident and COO | PPurchase | +225 | $3.37 | +$758.25 | New position225 after | |
| Nov 21, 2023 (view filing) | Nov 20 | 1 day | Windsor James BrianPresident and COO | PPurchase | +5.08K | $1.97 | +$10.0K | +11,034.8%5.12K after |